Lucy Day
Vermögen: 159 076 $ am 31.05.2026
Vermögen: 159 076 $ am 31.05.2026
Lucy O.
Day is currently Chief Financial Officer at AN2 Therapeutics, Inc. since 2019.
Formerly, Ms. Day was Vice President at Bank of America Corp.
from 1990 to 1994, Chief Financial Officer at Centaur Pharmaceuticals, Inc. from 1994 to 2002, and CFO, VP-Human Resources & Finance at Anacor Pharmaceuticals LLC from 2002 to 2016.
Education includes undergraduate studies at the University of California, Berkeley.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 36 738 ( 0,1 % ) | 159 076 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| AN2 THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.11.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| ANACOR PHARMACEUTICALS INC | Finanzdirektor/CFO | 01.08.2016 |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Finanzdirektor/CFO | 01.01.2002 |
| BANK OF AMERICA CORPORATION | Corporate Officer/Principal | 01.01.1994 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Bank of America Corp.
Bank of America Corp. Major BanksFinance Operates as a bank holding company whose subsidiaries provides consumer and global banking, markets brokerage & wealth and investment management services | Finance |
Centaur Pharmaceuticals, Inc.
Centaur Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen